Home >> Professional Blog

MiMedx to Present at 3rd Annual Regen Med Investor Day

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced that Deborah Dean, Executive Vice President, and Frank Burrows, Vice President, will represent the Company at the 3rd Annual Regen Med Investor Day in New York, New York.

The presentation will be conducted "investor conference" style, with a 5-minute introduction by the presenter, followed by a 10 minute 'fireside chat' discussion on stage with a leading research analyst.

The MiMedx timeslot is scheduled for Wednesday, March 25th, at 10:50 a.m. EDT, at the Metropolitan Club.

A webcast of this presentation will be available on the Company's website, www.mimedx.com.

Organized by the Alliance for Regenerative Medicine (ARM), in partnership with leading financial firms Maxim Group and Piper Jaffray, this one-day investor conference focuses exclusively on the regenerative medicine and advanced therapies sector.

The event includes clinical and commercial experts who will be on-hand to address specific questions regarding the outlook for the industry, as well as offer insight into how regenerative medicine products could impact the standard of care in key therapeutic areas.

The program will include talks by key opinion leaders in the industry, life science investment experts and analysts, as well as presentations by more than 30 leading companies from across the globe.